Calculate your SIP ReturnsExplore

|

O H L VOL


Days Range

About Venus Remedies

Incorporated in 1989 as Venus Glucose Pvt Ltd the company was converted into public limited company in 1994 and then changed into Venus Remedies Limited. The company was promoted and managed by Chaudhary & Family. The company was mainly engaged in I/V fluids & injectables,ceftazidime,amlodipine,gliclazide,lisinopril. The production was started in 1991 with Intravenous/Intramuscular injectible forms at Panchkula district at Haryana. In 1994 it introduced Eye/Ear/Nose drops. The company received the certificate as 'WHO-GMP' as specified by WHO,Geneva. Venus Remedies set up a Cephalosporin project with an Australian collaboration with US-FDA standards at a cost of Rs.4.5 crores. The company is manufacturing injections for the top companies like Panacea Biotech ltd,Morepan Labortories ltd etc. In 2001 with the help of Product Development Committee(PDC) Venus Remedies had introduced 13 new products in the Animal Health Division namely Megox-3000,Paroxin-3000,Pisa-3000,Mical,Ronid,Dexolyte and Detox.

Parent Organisation
Indian Private
Managing Director
Pawan Chaudhary
Founded
1989
NSE Symbol
VENUSREM

Peer Comparision

StocksMarket Cap (cr)Market Price (₹)52 Week Low-High (₹)

Venus Remedies Ltd FAQs

Venus Remedies Ltd (VENUSREM) share price as of May 30, 2024, on NSE is Rs 2,851.15 (NSE) and Rs 2,860.00 (BSE) on BSE.
Yes, You can buy Venus Remedies Ltd (VENUSREM) shares by opening a Demat account with Angel One.
Venus Remedies Ltd (VENUSREM) share can be bought through the following modes:
1. Direct investment: You can buy Venus Remedies Ltd (VENUSREM) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Venus Remedies Ltd (VENUSREM) shares.
Open Free Demat Account!

Enjoy Zero Brokerage on Equity Delivery

Join our 2 Cr+ happy customers

+91
Top Stocks

VIEW ALLView All Stocks

Top Gainers

    VIEW ALLView All Stocks

    Top Losers

      VIEW ALLView All Stocks

      Enjoy Zero Brokerage on Equity Delivery
      4.4 Cr+DOWNLOADS
      Enjoy Zero Brokerage on Equity Delivery

      Get the link to download the App

      Send App Link

      Enjoy Zero Brokerage on
      Equity Delivery